Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
36 Cards in this Set
- Front
- Back
3 zones of adrenal cortex and their products
|
Glomerulosa (mineralocorticoids), fasciculata (glucocorticoid=GC), and reticularis (adrenal androgens)
|
|
Pneumonic for 3 zones of adrenal cortex
|
GFR
|
|
Used for Addison's disease, Congenital Adrenal Hyperplasia (CAH), inflammation, allergies, and asthma (as a local inhalation)
|
Glucocorticoids
|
|
Short acting glucocorticoids
|
Cortisone and hydrocortisone (equivalent to cortisol)
|
|
Intermediate acting glucocorticoids
|
Prednisone, methylprednisolone, prednisolone, and triamcinolone
|
|
Long acting glucocorticoids
|
Betamethasone and dexamethasone
|
|
Mineralocorticoids
|
Fludrocortisone and deoxycorticosterone
|
|
Some side effects of corticosteroids
|
Osteopenia, impaired wound healing, inc. risk of infection, inc. appetite, HTN, edema, PUD, euphoria, psychosis, stria, thinning of skin
|
|
Period of time of therapy after which GC therapy will need to be tapered
|
5-7 days
|
|
Used for Cushing's syndrome (increased corticosteroid)
|
Dexamethasone suppression test
|
|
Inhibits conversion of cholesterol to pregnenolone therefore inhibiting corticosteroid synthesis
|
Aminoglutethimide
|
|
Antifungal agent used for inhibition of all gonadal and adrenal steroids
|
Ketoconazole
|
|
Antiprogestin used as potent antagonist of GC receptor
|
Mifepristone
|
|
Diuretic used to antagonize aldosterone receptors
|
Spironolactone
|
|
Common SE of spironolactone
|
Gynecomastia and hyperkalemia
|
|
Slightly increased risk of breast cancer, endometrial cancer, heart disease (questionable), has beneficial effects on bone loss
|
Estrogen
|
|
Antiestrogen drugs used for fertility and breast cancer respectively
|
Clomiphene and tamoxifen
|
|
Common SE of tamoxifen and raloxifene
|
Hot flashes
|
|
Selective estrogen receptor modulator (SERM) used for prevention of osteoporosis and prophylaxis in women with risk factors for breast cancer
|
Raloxifene
|
|
Non-steroidal estrogen agonist causes clear cell adenocarcinoma of the vagina in daughters of women who used it during pregnancy
|
Diethylstilbestrol (DES)
|
|
Estrogen mostly used in oral contraceptives (OC)
|
Ethinyl estradiol and mestranol
|
|
Anti-progesterone used as abortifacient
|
Mifepristone (RU-486)
|
|
Constant low dose of estrogen and increasing dose of progestin for 21 days (last 5 days are sugar pills or iron prep)
|
Combination oral contraceptives (OC)
|
|
Oral contraceptive available in a transdermal patch
|
Ortho-Evra
|
|
Converted to more active form DHT by 5 alpha-reductase
|
Testosterone
|
|
5 alpha-reductase inhibitor used for benign prostatic hyperplasia (BPH) and male pattern baldness
|
Finasteride (Proscar and Propecia respectively)
|
|
Anabolic steroid that has potential for abuse
|
Nandrolone, oxymetholone, and oxandrolone
|
|
Anti-androgen used for hirsutism in females
|
Cyproterone acetate
|
|
Drug is used with testosterone for male fertility
|
Leuprolide
|
|
Anti-estrogen used for estrogen receptor + breast cancer
|
Tamoxifen
|
|
Newer estrogen receptor antagonist used in advanced breast cancer
|
Toremifene (Fareston)
|
|
Increase bone density, also being tested for breast CA prophylaxis
|
Raloxifene (SERM-selective estrogen receptor modulator)
|
|
Aromatase inhibitor used in breast cancer
|
Letrozole, anastrozole
|
|
Anti-androgen used for prostate cancer
|
Flutamide (Eulexin)
|
|
SE seen only in men with administration of ketoconazole
|
Gynecomastia
|
|
Inhibitors of CYP450
|
Cimetidine, ketoconazole, erythromycin, isoniazid and grapefruit
|